Michael F. Demane - Dec 31, 2021 Form 4 Insider Report for NEVRO CORP (NVRO)

Role
Director
Signature
/s/ Kashif Rashid, as Attorney-in-Fact for Michael DeMane
Stock symbol
NVRO
Transactions as of
Dec 31, 2021
Transactions value $
$0
Form type
4
Date filed
1/4/2022, 05:01 PM
Previous filing
Oct 4, 2021
Next filing
Apr 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVRO Common Stock Award $0 +323 +0.73% $0.00 44.4K Dec 31, 2021 Direct F1, F2
holding NVRO Common Stock 149K Dec 31, 2021 See footnote F3
holding NVRO Common Stock 67.3K Dec 31, 2021 See footnote F4
holding NVRO Common Stock 11.6K Dec 31, 2021 See footnote F5
holding NVRO Common Stock 48K Dec 31, 2021 See footnote F6
holding NVRO Common Stock 49.9K Dec 31, 2021 See footnote F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested restricted stock. The restricted stock represent quarterly retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash.
F2 Includes 1,167 restricted stock units.
F3 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
F4 Shares held by Michael DeMane Trustee, Michael F. DeMane 2016 Retained Annuity Trust U/A/D May 22, 2017.
F5 Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011.
F6 Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 04/23/2021.
F7 Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 08/13/2021.